(Q38042295)

27 August 2017

Severe heart failure after bortezomib treatment in a patient with multiple myeloma: a case report and review of the literature (English)

1 reference

27 August 2017

0 references

1 reference

Margarita Bockorny

1

1 reference

27 August 2017

Saneka Chakravarty

2

1 reference

27 August 2017

Peter Schulman

3

1 reference

27 August 2017

Bruno Bockorny

4

1 reference

27 August 2017

Robert Bona

5

1 reference

27 August 2017

4 September 2012

1 reference

27 August 2017

1 reference

27 August 2017

128

1 reference

27 August 2017

4

1 reference

27 August 2017

244-247

1 reference

The proteasome: a suitable antineoplastic target

27 August 2017

1 reference

Randomized phase II trial of concurrent versus sequential bortezomib plus docetaxel in advanced non-small-cell lung cancer: a California cancer consortium trial.

21 January 2018

1 reference

A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer

21 January 2018

1 reference

Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

21 January 2018

1 reference

A phase 2 study of bortezomib in relapsed, refractory myeloma

21 January 2018

1 reference

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma

21 January 2018

1 reference

Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report

21 January 2018

1 reference

Acute severe cardiac failure in a myeloma patient due to proteasome inhibitor bortezomib

21 January 2018

1 reference

Myocardial scarring following chemotherapy for multiple myeloma detected using late gadolinium hyperenhancement cardiovascular magnetic resonance.

21 January 2018

1 reference

Ischemic heart disease associated with bortezomib treatment combined with dexamethasone in a patient with multiple myeloma

21 January 2018

1 reference

The proteasome: structure, function, and role in the cell

21 January 2018

1 reference

The ubiquitin-proteasome system: focus on the heart.

21 January 2018

1 reference

The ubiquitin-proteasome system in cardiac physiology and pathology

21 January 2018

1 reference

Early anthracycline cardiotoxicity

21 January 2018

1 reference

Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis

21 January 2018

1 reference

Cardiovascular magnetic resonance in cardiac amyloidosis

21 January 2018

1 reference

Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches.

21 January 2018

1 reference

Cardiac magnetic resonance imaging in sunitinib malate-related cardiomyopathy: no late gadolinium enhancement.

21 January 2018

1 reference

Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy

21 January 2018

1 reference

Carfilzomib: a novel second-generation proteasome inhibitor

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000340050

1 reference

27 August 2017

1 reference